Ribo Life Science

Suzhou, China · Founded 2007 · Publicly Held

Developer and provider of RNA interference ( RNAi ) technology designed to treat liver diseases. Ribo Life Science is based in Suzhou, China and was founded in 2007. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.2 billion (Jan 2026). It has raised $285 million.

Last price · $/share

—

Implied valuation

$1.2B

Total raised

$285.3M

Last round

—

How much has Ribo Life Science raised?

$285.3Macross 0 recorded rounds

Free account

More of Ribo Life Science with a free account

·The complete investor list: 12 names
·Watch Ribo Life Science: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Ribo Life Science investors

12 investors are on record for Ribo Life Science, including CICC Capital, Kunshan Hi-tech Venture Capital, China Asset Management Company and Springs Capital.

For fundraisers

Raising for a company like Ribo Life Science?

12 investors have backed Ribo Life Science.

See all 12 investors →

Frequently asked about Ribo Life Science

How much has Ribo Life Science raised?: Ribo Life Science has raised $285.3M in total across 0 recorded funding rounds.